E. I. Du Pont De Nemours And Company Stock Earnings Reports
Buy CTA-PB
E. I. Du Pont De Nemours And Company Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | - |
| EPS actual | $1.07 |
| Revenue estimate | - |
| Revenue actual | 4.905B |
| Release date | Feb 12, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Nov 05, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | 2.618B |
| Release date | Aug 04, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for E. I. Du Pont De Nemours And Company
Below you can see how CTA-PB performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 04, 2025 |
| Price on release | $69.40 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 29, 2025 | $69.80 |
| Jul 30, 2025 | $69.84 |
| Jul 31, 2025 | $69.62 |
| Aug 01, 2025 | $69.36 |
| Aug 04, 2025 | $69.40 |
| Aug 05, 2025 | $69.40 |
| Aug 06, 2025 | $69.87 |
| Aug 07, 2025 | $69.25 |
| Aug 08, 2025 | $69.65 |
| 4 days before | -0.573% |
| 4 days after | 0.360% |
| On release day | 0% |
| Change in period | -0.215% |
| Release date | Nov 05, 2025 |
| Price on release | $69.45 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Oct 30, 2025 | $69.35 |
| Oct 31, 2025 | $69.33 |
| Nov 03, 2025 | $69.48 |
| Nov 04, 2025 | $69.45 |
| Nov 05, 2025 | $69.45 |
| Nov 06, 2025 | $69.91 |
| Nov 07, 2025 | $69.89 |
| Nov 10, 2025 | $69.89 |
| Nov 11, 2025 | $68.25 |
| 4 days before | 0.144% |
| 4 days after | -1.73% |
| On release day | 0.662% |
| Change in period | -1.59% |
| Release date | Feb 12, 2026 |
| Price on release | $67.88 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Feb 06, 2026 | $67.89 |
| Feb 09, 2026 | $67.97 |
| Feb 10, 2026 | $67.85 |
| Feb 11, 2026 | $68.00 |
| Feb 12, 2026 | $67.88 |
| Feb 13, 2026 | $67.90 |
| Feb 17, 2026 | $68.42 |
| Feb 18, 2026 | $68.55 |
| Feb 19, 2026 | $68.38 |
| 4 days before | -0.0147% |
| 4 days after | 0.737% |
| On release day | 0.0290% |
| Change in period | 0.722% |
| Release date | May 06, 2026 |
| Price on release | $68.37 |
| EPS estimate | - |
| EPS actual | $1.07 |
| Date | Price |
|---|---|
| Apr 30, 2026 | $68.96 |
| May 01, 2026 | $68.96 |
| May 04, 2026 | $68.15 |
| May 05, 2026 | $68.72 |
| May 06, 2026 | $68.37 |
| May 07, 2026 | $68.45 |
| May 08, 2026 | $68.23 |
| May 11, 2026 | $68.16 |
| May 12, 2026 | $68.37 |
| 4 days before | -0.86% |
| 4 days after | 0.0102% |
| On release day | 0.118% |
| Change in period | -0.85% |
E. I. Du Pont De Nemours And Company Earnings Call Transcript Summary of Q1 2026
Q1 2026 highlights: Corteva delivered a strong start to 2026 with organic sales up 7% and operating EBITDA up 21% (margin expansion of ~240 bps). Both Seed and Crop Protection showed double-digit EBITDA gains, driven by price/mix, volume (notably new seed hybrids/varieties and CP new products/Spinosyns), cost/productivity improvements, and a currency tailwind. The company reaffirmed full-year guidance: operating EBITDA $4.0–$4.2 billion, operating EPS $3.45–$3.70, and mid/low- to mid-single-digit volume growth expectations (seed mid single-digit, CP modest growth). Management noted continued strength in demand for premium technologies, progress toward becoming royalty positive later in 2026, and momentum on growth platforms (licensing, biologicals, hybrid wheat, gene editing). Separation progress: on track for a Q4 separation, initial Form 10 filed, leadership teams named, new seed company brand announced (Vylor); estimated one-time separation costs of ~$350 million and net dis-synergies trending better than prior $100M estimate (guide includes $50M). Capital allocation: plan to repurchase ~$500M in H1 and a board-approved $1.5B discretionary pension contribution to help both new entities achieve investment-grade credit profiles. Key risks/near-term watch items: higher oil/energy prices (modeled as a ~$40M headwind in back half), tariff movement (slightly favorable vs. prior assumptions), geopolitical uncertainty (Middle East), seasonal timing shifts between Q1 and Q2, and potential regional acreage/mix changes (US corn/soy mix, Brazil safrinha). Management reiterated focus on controllable levers (pricing for value, productivity, input-cost management) and expects a better-than-expected first half while monitoring upside/downside into H2.
Sign In